Inventor · disambiguated record
Vadim Kraynov
Also filed as: KRAYNOV VADIM
31 granted patents·10 pending applications·354 citations·filing 2003–2023
97Inventor score
Top patents by PatentIndex Score
41 records- 0198US8012931B2Modified FGF-21 polypeptides and their usesAMBRX INC·Filed 2008·Granted Sep 6, 2011·76 cites·52 claims
- 0296US10253083B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted Apr 9, 2019·11 cites·20 claims
- 0396US8383365B2Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivativesAMBRX INC·Filed 2011·Granted Feb 26, 2013·48 cites·60 claims
- 0495US10751391B2Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acidAMBRX INC·Filed 2019·Granted Aug 25, 2020·6 cites·24 claims
- 0595US8735539B2Relaxin polypeptides comprising non-naturally encoded amino acidsKRAYNOV VADIM·Filed 2011·Granted May 27, 2014·36 cites·58 claims
- 0694US10702588B2Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chainAMBRX INC·Filed 2018·Granted Jul 7, 2020·7 cites·20 claims
- 0794US9975936B2Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2016·Granted May 22, 2018·12 cites·20 claims
- 0894US9567386B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2013·Granted Feb 14, 2017·14 cites·12 claims
- 0994US9079971B2Modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2013·Granted Jul 14, 2015·19 cites·39 claims
- 1093US9517273B2Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2015·Granted Dec 13, 2016·15 cites·20 claims
- 1192US9962450B2Method of treating heart failure with modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted May 8, 2018·9 cites·21 claims
- 1292US8329869B2Modified interferon beta polypeptides and their usesKRAYNOV VADIM·Filed 2012·Granted Dec 11, 2012·21 cites·6 claims
- 1391US9452222B2Nucleic acids encoding modified relaxin polypeptidesAMBRX INC·Filed 2014·Granted Sep 27, 2016·14 cites·19 claims
- 1490US8114630B2Modified interferon beta polypeptides and their usesKRAYNOV VADIM·Filed 2008·Granted Feb 14, 2012·18 cites·4 claims
- 1589US8093356B2Pegylated human interferon polypeptidesHAYS ANNA-MARIA A·Filed 2007·Granted Jan 10, 2012·19 cites·5 claims
- 1687US2024189392A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2023·Application pending·0 cites
- 1786US10961291B2Modified FGF-21 polypeptides and their usesAMBRX INC·Filed 2019·Granted Mar 30, 2021·1 cites·26 claims
- 1884US10954270B2Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivativesAMBRX INC·Filed 2017·Granted Mar 23, 2021·2 cites·13 claims
- 1984US10377805B2Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their usesAMBRX INC·Filed 2018·Granted Aug 13, 2019·2 cites·21 claims
- 2084US9796754B2Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivativesMIAO ZHENWEI·Filed 2012·Granted Oct 24, 2017·8 cites·56 claims
- 2184US8946148B2Modified insulin polypeptides and their usesMIAO ZHENWEI·Filed 2008·Granted Feb 3, 2015·6 cites·3 claims
- 2281US11786578B2Modified relaxin polypeptides and their usesAMBRX INC·Filed 2022·Granted Oct 17, 2023·0 cites·19 claims
- 2381US2023028168A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2022·Application pending·0 cites
- 2477US11993637B2Modified FGF-21 polypeptides with non-naturally encoded amino acidsAMBRX INC·Filed 2021·Granted May 28, 2024·0 cites·20 claims
- 2576US7662644B2Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparationSCRIPPS RESEARCH INST·Filed 2007·Granted Feb 16, 2010·2 cites·18 claims
- 2675US7176037B2Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparationSCRIPPS RESEARCH INST·Filed 2003·Granted Feb 13, 2007·4 cites·6 claims
- 2775US2023348547A1Modified bovine g-csf polypeptides and their usesAMBRX INC·Filed 2022·Application pending·0 cites
- 2874US9938333B2Modified leptin polypeptides and their usesKRAYNOV VADIM·Filed 2009·Granted Apr 10, 2018·2 cites·9 claims
- 2973US11311605B2Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptidesAMBRX INC·Filed 2020·Granted Apr 26, 2022·0 cites·24 claims
- 3073US2022411469A1Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivativesAMBRX INC·Filed 2022·Application pending·0 cites
- 3172US11439710B2Nucleic acids encoding modified relaxin polypeptidesAMBRX INC·Filed 2020·Granted Sep 13, 2022·0 cites·20 claims
- 3271US10138283B2Modified bovine G-CSF polypeptides and their usesHAYS PUTNAM ANNA MARIA A·Filed 2009·Granted Nov 27, 2018·2 cites·4 claims
- 3368US11420999B2Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivativesAMBRX INC·Filed 2021·Granted Aug 23, 2022·0 cites·11 claims
- 3466US11542310B2Modified bovine G-CSF polypeptides and their usesAMBRX INC·Filed 2018·Granted Jan 3, 2023·0 cites·6 claims
- 3552US7745377B2Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparationSCRIPPS RESEARCH INST·Filed 2005·Granted Jun 29, 2010·0 cites·7 claims
- 3652US2015299288A1Modified Insulin Polypeptides and Their UsesAMBRX INC·Filed 2014·Application pending·0 cites
- 3751US2010135959A1Human Interferon Molecules and Their UsesAMBRX INC·Filed 2006·Application pending·0 cites
- 3851US2011178029A1Modified Human Apolipoprotein A-1 and Their UsesAMBRX INC·Filed 2008·Application pending·0 cites
- 3944US2015080559A1Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acid Linked Dolastatin DerivativesAMBRX INC·Filed 2012·Application pending·0 cites
- 4038US2012283172A1Modified porcine somatotropin polypeptides and their usesWALLEN III JOHN W·Filed 2010·Application pending·0 cites
- 4137US2015031864A1Modified Adiponectin Polypeptides and Their UsesAMBRX INC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →